SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech & Nutrition informs about scrutinizers report

28 Sep 2024 Evaluate
Pursuant to Regulation 44 of (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emmessar Biotech & Nutrition has informed that the Reports of Scrutinizer on remote e-voting and e-voting conducted at the 32nd Annual General meeting (AGM) of the Company held on Friday, September 27, 2024 are enclosed. This is also being made available at the website of the Company i.e., www.ebnl.org

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

26.00 0.20 (0.78%)
16-Apr-2026 13:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1681.40
Dr. Reddys Lab 1222.95
Cipla 1231.25
Zydus Lifesciences 936.25
Lupin 2307.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×